The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer-Reference-Cited by-同舟云学术

The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer

Published:2017-02-15 Issue:3 Volume:17 Page:191-198
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Minion Lindsey E.¹,Tewari Krishnansu S.¹

Affiliation:

1. The Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of California, Irvine Medical Center, Orange, CA, USA

Funder

NIH

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1246187

Reference46 articles.

1. American Cancer Society. Facts and Figures, 2017. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf.

2. Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis

3. Clinical implications for cediranib in advanced cervical cancer

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-targeting drug delivery regimens based on vascular disrupting agents;Precision Medicine and Engineering;2024-09

2. Immunohistochemical Expression of Survivin and Vascular Endothelial Growth Factor in Cervical Squamous Cell Carcinoma;Indian Journal of Surgical Oncology;2024-08-06

3. Advances in Targeted Therapy for the Treatment of Cervical Cancer;Journal of Clinical Medicine;2023-09-15

4. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions;MedComm;2023-09-14

5. Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report;BMC Nephrology;2023-03-10